Skip to content

Quality of Analgesia After Interscalene Block After Arthroscopic Shoulder Surgery

Quality of Analgesia After Interscalene Block With Bupivacaine and Exparel® vs. Bupivacaine Alone After Arthroscopic Shoulder Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02554357
Enrollment
50
Registered
2015-09-18
Start date
2015-07-31
Completion date
2016-03-31
Last updated
2016-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury of Shoulder Region

Brief summary

Shoulder arthroscopic causes post operative pain that outlasts analgesia provided by single injection nerve blocks.

Detailed description

The interscalene brachial plexus block (ISBPB) is a common analgesic technique for procedures of the shoulder and upper arm. Moreover, the incidence of rebound pain is well documented and is often of considerable discomfort to patients, who may quickly go from little or no pain to moderate-severe pain. Continuous nerve block techniques with home ambulatory catheters are currently utilized to manage postoperative pain.This study is designed to compare the level and duration of pain control of Exparel® injected after bupivacaine via stop-cock connected syringes and bupivacaine alone for ISBPB.

Interventions

DRUGExparel block in arthroscopic shoulder surgery

The interscalene block will be performed with ultrasound guidance and nerve stimulation.

DRUGBupivacaine block in shoulder surgery

The interscalene block will be performed with ultrasound guidance and nerve stimulation.

Sponsors

New York School of Regional Anesthesia
CollaboratorOTHER
Pacira Pharmaceuticals, Inc
CollaboratorINDUSTRY
North American Institute for Continuing Medical Education (NAICE)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Dutch or English speaking adults * 18 years or older ASA I-III physical class * Scheduled for elective arthroscopic shoulder surgery

Exclusion criteria

* History of allergy to a local anesthetic * Baseline neurological deficit * Medical condition that would make it difficult to assess sensory distribution or communicate with the investigators' staff * Recent history (\< 3 months) of drug or alcohol abuse * Concomitant opioid therapy * Preexisting coagulation disorder * Infection at the injection site * Pregnancy

Design outcomes

Primary

MeasureTime frame
Worst painassessed by the Modified Brief Pain Inventory short form Question 1 in the first postoperative week - postoperative day (POD) 1 through POD7
Satisfaction with analgesiaassessed by the Overall Benefit of Analgesia Score (OBAS) in the first postoperative week postoperative day (POD)1 through POD7

Secondary

MeasureTime frame
Onset of motor blockonset will be measured up to 30 minutes
Onset of sensory blockonset will be measured up to 30 minutes
functionality of the surgical armassessed on the scale 0-5 in the first postoperative week - postoperative day (POD) 2- POD7
duration of motor blockduration will be measured up to 72 hours
Duration of sensory blockduration will be measured up to 72 hours

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026